PACE

 

PROVIDER BULLETIN

 

MANUFACTURERS’ REBATE

 

April 28, 2006

 

Act 128-1992 amending the Lottery Fund Preservation Act, in part, requires all pharmaceutical manufacturers to have in effect a rebate agreement with the PACE Program if they wish to have their products covered.  In effecting the rebate provisions of Act 134-1996, PACE, the Chronic Renal Disease Program (CRDP) and the Special Pharmaceutical Benefits Program (SPBP) will preclude payment for all products marketed by those manufacturers who either have not signed a PACE rebate agreement or have not complied with the agreement provisions.

 

Please note the following manufacturer is being added to PACE’s non-participating list:

 

          NABI (North American Biological Inc) Labeler Code – 59730

 

NOTE: NABI has the exclusive rights to Phoslo®. 

 

All products of NABI, including Phoslo®, are no longer reimbursable effective May 29, 2006.

 

Questions regarding this bulletin should be directed to:

Nabi Biopharmaceuticals

Corporate Headquarters and Manufacturing Facility

5800 Park of Commerce Blvd., N.W.

Boca Raton, Florida

1-800-865-1766